After Avandia: Does the FDA Have a Drug Problem? A TIME investigation of Avandia's journey from lab to pharmacy reveals serious flaws in the way the Food and Drug Administration protects consumers from harmful medicines By Massimo Calabresi with Alice Park Thursday, Aug. 12, 2010 Share Tweet Read Later Send to Kindle